Human American trypanosomiasis is resurgent in Latin Americans, and new drugs are urgently required as current medications suffer from a number of drawbacks. Some nitroheterocycles have been demonstrated to exert a potent activity against trypanosomes. However, host toxicity issues halted their development as trypanocides. As part of the efforts to develop new compounds in order to treat parasitic infections, it is important to define their structure–activity relationship. In this study, 5-nitromegazol and two of its analogues, 4-nitromegazol, and 1-methyl-5-nitro-2-imidazolecarboxaldehyde 5-nitroimidazole- thiosemicarbazone, were tested and compared for in vitro induction of DNA damage in human leukocytes by the comet assay, performed at different pHs to better identify the types of damage. Specific oxidatively generated damage to DNA was also measured by using the comet assay with endonucleases. DNA damage was found in 5-nitromegazol-treated cells: oxidative stress appeared as the main source of DNA damage. 4-Nitromegazol did not produce any significant effect, thus confirming that 4-nitroimidazoles isomers have no important biological activity. The 5-nitroimidazole-thiosemicarbazone induced DNA damage with a higher efficiency than 5-nitromegazol. The central role in the reduction process played by the acidic hydrazine proton present in the thiosemicarbazone group but not in the cyclic (thiadiazole) form can contribute to rationalise our results. Given its versatility, thiosemicarbazone moiety could be involved in different reactions with nitrogenous bases (nucleophilic and/or electrophilic attacks).

Trypanocidal nitroimidazole derivatives: relationships among chemical structure and genotoxic activity / Buschini, Annamaria; Giordani, F; NORTHFLEET DE ALBUQUERQUE, C; Pellacani, Claudia; Pelosi, Giorgio; Rossi, Carlo; Zucchi, Tmad; Poli, Paola. - In: BIOCHEMICAL PHARMACOLOGY. - ISSN 0006-2952. - 73:(2007), pp. 1537-1547. [10.1016/j.bcp.2007.01.024]

Trypanocidal nitroimidazole derivatives: relationships among chemical structure and genotoxic activity.

BUSCHINI, Annamaria;PELLACANI, Claudia;PELOSI, Giorgio;ROSSI, Carlo;POLI, Paola
2007-01-01

Abstract

Human American trypanosomiasis is resurgent in Latin Americans, and new drugs are urgently required as current medications suffer from a number of drawbacks. Some nitroheterocycles have been demonstrated to exert a potent activity against trypanosomes. However, host toxicity issues halted their development as trypanocides. As part of the efforts to develop new compounds in order to treat parasitic infections, it is important to define their structure–activity relationship. In this study, 5-nitromegazol and two of its analogues, 4-nitromegazol, and 1-methyl-5-nitro-2-imidazolecarboxaldehyde 5-nitroimidazole- thiosemicarbazone, were tested and compared for in vitro induction of DNA damage in human leukocytes by the comet assay, performed at different pHs to better identify the types of damage. Specific oxidatively generated damage to DNA was also measured by using the comet assay with endonucleases. DNA damage was found in 5-nitromegazol-treated cells: oxidative stress appeared as the main source of DNA damage. 4-Nitromegazol did not produce any significant effect, thus confirming that 4-nitroimidazoles isomers have no important biological activity. The 5-nitroimidazole-thiosemicarbazone induced DNA damage with a higher efficiency than 5-nitromegazol. The central role in the reduction process played by the acidic hydrazine proton present in the thiosemicarbazone group but not in the cyclic (thiadiazole) form can contribute to rationalise our results. Given its versatility, thiosemicarbazone moiety could be involved in different reactions with nitrogenous bases (nucleophilic and/or electrophilic attacks).
2007
Trypanocidal nitroimidazole derivatives: relationships among chemical structure and genotoxic activity / Buschini, Annamaria; Giordani, F; NORTHFLEET DE ALBUQUERQUE, C; Pellacani, Claudia; Pelosi, Giorgio; Rossi, Carlo; Zucchi, Tmad; Poli, Paola. - In: BIOCHEMICAL PHARMACOLOGY. - ISSN 0006-2952. - 73:(2007), pp. 1537-1547. [10.1016/j.bcp.2007.01.024]
File in questo prodotto:
File Dimensione Formato  
2007 Biochem Pharmacol.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 773.1 kB
Formato Adobe PDF
773.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2295851
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 24
social impact